These brain areas are also linked to impulsivity and emotional control in people with ADHD. By reducing food cravings and constant thoughts about eating, GLP⁠-1s may help some people feel more focused ...

Months after promising help for “hundreds of thousands of kids,” the FDA approved the decades-old medicine for a disease documented in less than 50 people.

Wegovy users have five times the risk of experiencing permanent sight loss linked to weight loss jabs than those taking other ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of 'eye stroke' (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:00 AM EDTCompany ParticipantsAndrew Obenshain - CEO ...

FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.

The number of new monthly dispensations of ADHD drugs to adults in Ontario more than doubled after the onset of the COVID pandemic.